Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
An exciting opportunity awaits with a leading NHS trust in London as a Deputy Charge Nurse for the innovative UCLH@Home Blood Transfusion pathway. This role offers the chance to provide exceptional patient care in a community setting, ensuring patients transition safely from hospital to home. Join a dynamic team dedicated to integrating care and improving health outcomes for diverse populations. Be part of a forward-thinking organization committed to sustainability and excellence in healthcare, where your contributions will make a real difference in the lives of patients.
Client: University College London Hospitals
Location: London, United Kingdom
Job Category: Other
EU work permit required: Yes
Job Reference: 4fd6b6176fdb
Job Views: 4
Posted: 02.05.2025
Expiry Date: 16.06.2025
An exciting opportunity has arisen to join our UCLH@HOME team as we pilot a new Blood Transfusion pathway. We are at the forefront of integrated care, providing innovative and transformational services that best serve local communities.
UCLH@Home is an NHS service supporting patients to leave hospital once medically optimized and safe to be managed in the community, while remaining under the care of their consultant team. Your role will involve direct care delivery within patients' homes, primarily working within the new Blood Transfusion pathway. This role requires an innovative individual comfortable working flexibly.
University College London Hospitals NHS Foundation Trust (UCLH) is one of the most complex NHS trusts in the UK, serving a diverse population with a range of acute and specialist services. Our vision is to deliver top-quality patient care, excellent education, and world-class research.
We operate across eight sites, including:
UCLH specializes in complex illnesses including women’s health, cancer, infections, neurology, gastrointestinal, and oral diseases, supported by advanced services like critical care, imaging, nuclear medicine, and pathology. We are committed to sustainability, aiming for net zero emissions by 2031 (direct) and 2040 (indirect).